文献速递临床血液与体液分子诊断

如何诊断低危型骨髓增生异常综合征

How I Diagnose Low-Grade Myelodysplastic Syndromes.
PubMed 文献 · Am J Clin Pathol · 2020-01-01

本文讨论低危型骨髓增生异常综合征(MDS,缺乏原始细胞增多)的诊断方法,提出诊断算法并附两例示例病例。强调需整合外周血检查、骨髓形态学、遗传学及临床记录以排除继发性血细胞减少,并谨慎解读克隆性造血相关结果。

要点

  • 低危型MDS诊断需整合外周血、骨髓形态、遗传学及临床记录排除继发原因。
  • 辅助检查应支持或质疑形态学发育异常所提示的低危型MDS可能性。
  • 解读细胞遗传学和二代测序需结合意义未明克隆性造血的新知识。

核心结论

  • 病理学家在低危型MDS诊断中整合多源数据的角色不断演变且日益复杂,应保持保守态度并接受不确定性。

研究设计与样本

  • 本文为诊断方法论述,提出低危型MDS(缺乏原始细胞增多)的诊断算法并展示两例示例病例。

主要发现

  • 低危型MDS的诊断困境常在于与其他血细胞减少原因鉴别,需整合外周血细胞计数参数与形态、骨髓形态、遗传学及临床记录。
  • 辅助检查的恰当使用对支持或质疑低危型MDS的可能性很重要,需与形态学发育异常发现结合。
  • 细胞遗传学和二代测序结果的解读具有挑战性,必须纳入意义未明克隆性造血的新知识。

临床怎么用

  • 诊断低危型MDS时应系统整合外周血、骨髓形态、遗传学和临床记录以排除继发性血细胞减少。
  • 解读细胞遗传学和二代测序结果时需结合意义未明克隆性造血知识,保持保守方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Myelodysplastic syndromes (MDS) are a group of myeloid neoplasms that are often difficult to diagnose due to their pathologic and clinical heterogeneity. The key features of MDS are peripheral blood cytopenias, ineffective hematopoiesis manifesting as morphologic dysplasia, and clonal genetic abnormalities. The most difficult diagnostic dilemmas often arise in low-grade MDS cases (lacking excess blasts), which can be difficult to distinguish from other causes of cytopenia. This distinction requires the integration of information from the peripheral blood (both CBC parameters and morphology), bone marrow morphology, genetic studies, and interrogation of the clinical record to exclude secondary causes. METHODS: We discuss the approach to the diagnosis of low-grade MDS (cases lacking increased blasts), including a diagnostic algorithm and two illustrative cases. RESULTS: The appropriate use of ancillary studies is important to support or dispute the likelihood of low-grade MDS in conjunction with the findings of morphologic dysplasia. Interpreting the results of cytogenetics and next-generation sequencing can be challenging and must incorporate the emerging knowledge of clonal hematopoiesis of indeterminate potential. CONCLUSIONS: The role of pathologists in integrating data from multiple sources in the diagnosis of low-grade MDS is evolving and becoming increasingly complex; in this challenging diagnostic setting, it is important to feel comfortable with uncertainty and maintain a conservative approach.

来源:Am J Clin Pathol,查看原文。版权归原作者所有。

引用

  1. Siddon AJ, Hasserjian RP. How I Diagnose Low-Grade Myelodysplastic Syndromes. Am J Clin Pathol. 2020. PMID: 32458977. doi:10.1093/ajcp/aqaa046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。